This is interesting given the discovery by Ibiza et al., which showed that ligands of the GDNF family derived from enteric glial cells were able to activate the RET receptor on type 3 innate lymphoid cells modulating the release of cytokines such as IL22, which are integral to epithelial protection in colitis [37]. This evidence concerns the gene IL22 and colitis.